FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
Clinical trial NCT05077800 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05077800
- Sponsor
- Colin D. Weekes, M.D., PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2026-12-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.